{
    "organizations": [],
    "uuid": "18d6fe5034e6e1dbd67aec2376d452cdc733e3ec",
    "author": "Peter Loftus",
    "url": "https://www.wsj.com/articles/orexigen-bankruptcy-shows-difficulty-of-marketing-weight-loss-drugs-1520886182",
    "ord_in_thread": 0,
    "title": "Orexigen Bankruptcy Shows Difficulty of Marketing Weight-Loss Drugs",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Drugmaker Orexigen Therapeutics Inc. filed for bankruptcy protection on Monday and plans to sell itself, after failing to find a profitable market for its weight-loss treatment Contrave.\nThe move underscores the difficulties the pharmaceutical industry has encountered in finding a safe and effective diet drug in the two decades since a drug that was part of the popular “fen-phen” treatment was pulled from the market because it was causing heart problems in patients.\n...  ",
    "published": "2018-03-12T23:23:00.000+02:00",
    "crawled": "2018-03-12T23:02:45.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "drugmaker",
        "orexigen",
        "therapeutic",
        "filed",
        "bankruptcy",
        "protection",
        "monday",
        "plan",
        "sell",
        "failing",
        "find",
        "profitable",
        "market",
        "treatment",
        "contrave",
        "move",
        "underscore",
        "difficulty",
        "pharmaceutical",
        "industry",
        "encountered",
        "finding",
        "safe",
        "effective",
        "diet",
        "drug",
        "two",
        "decade",
        "since",
        "drug",
        "part",
        "popular",
        "treatment",
        "pulled",
        "market",
        "causing",
        "heart",
        "problem",
        "patient"
    ]
}